Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,724 | -5,001 | -3,324 | -1,928 | -718 |
| Depreciation Amortization | 13 | 114 | 77 | 50 | 25 |
| Other Working Capital | -109 | -114 | 62 | -483 | 150 |
| Other Operating Activity | 162 | 1,297 | 626 | 457 | 171 |
| Operating Cash Flow | $-1,659 | $-3,704 | $-2,559 | $-1,904 | $-372 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,203 | 4,925 | 2,553 | 1,907 | 295 |
| PPE Investments | N/A | -150 | -56 | N/A | N/A |
| Investing Cash Flow | $1,203 | $4,776 | $2,497 | $1,907 | $295 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 0 | 1 | 0 | 1 | 1 |
| Beginning Cash Position | 1,288 | 215 | 215 | 215 | 215 |
| End Cash Position | 832 | 1,288 | 153 | 219 | 139 |
| Net Cash Flow | $-456 | $1,073 | $-62 | $4 | $-77 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,659 | -3,704 | -2,559 | -1,904 | -372 |
| Capital Expenditure | N/A | -150 | -56 | N/A | N/A |
| Free Cash Flow | -1,659 | -3,854 | -2,615 | -1,904 | -372 |